Updated my back of envelope notes to reflect today's announcement. Changed some of the column names to reflect future regional growth. South America centres can't be too far away.
* Over two and half weeks to go until the March 15 quarter is complete.
* Over 60 centres reordering CardioCel - not including the centres in Australia
* No info on Canadian and Hong Kong centres as yet but CC is approved for use in both these regions
* The number of North America centres is now equal to the number of European centres. Note CardioCel has been approved for use in the European market longer than the U.S
Have a good look at the number of surgeries from the Jan-15 quarter to today's announcement. More than doubled within a quarter. * Note that 553 figure was taken from another source and not from AHZ.
So does anybody believe that exponential growth has yet to start ?
As always - do you own research.
Haplo
Ann: Admedus expands CardioCel market, page-103
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.25 |
Change
0.000(0.00%) |
Mkt cap ! $301.2M | |||
| Open | High | Low | Value | Volume |
| $14.20 | $14.76 | $13.70 | $355.0K | 25.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 988 | $14.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.99 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |